Trending...
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
SAN JOSE, Calif. - ncarol.com -- CPC announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods Administration (TGA), the country's government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic goods. As a globally recognized peptide and oligonucleotide manufacturer, with our facilities built and operated to WHO GMP, FDA 21 CFR 210/211, and ICH Q7 standards, this audit marks a significant milestone in the company's ongoing commitment to ensuring the highest standards of quality and compliance. Our manufacturing facility in Hangzhou, China, was awarded an A2 compliance rating. This inspection certifies Good Manufacturing Practice (GMP) compliance of three commercial peptide active pharmaceutical ingredients (APIs). This achievement underscores our commitment to maintaining the highest quality standards in peptide production and ensures that our products meet stringent international regulatory requirements.
More on ncarol.com
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on ncarol.com
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
More on ncarol.com
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- New Slotozilla Project Explores What Happens When the World Goes Silent
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on ncarol.com
- The Two Faces of Charles D. Braun: How the Novel, Posthumously Yours, Came to Life
- Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
- Marty the Martian Farmer: A Retro Sci-Fi Comedy with a Cosmic Twist
- Athena Forge (ATFG) Introduces Advanced Token for Technology-Driven Financial Ecosystem
- Albuquerque's Z-CoiL Footwear Brings All-American Family Business Story to Shark Tank Season Premiere
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
Source: CPC Scientific Inc.
0 Comments
Latest on ncarol.com
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
- Nashville International Chopin Piano Competition Partners with Crimson Global Academy to Support Excellence in Education
- Entrinsicon 2025 Returns to Raleigh, Showcases AI and Data Innovation
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution
- NIUFO Examines European MiCA Regulation's Impact on Digital Asset Trading Markets
- Wzzph Analyzes Crypto Market Maturation as Institutional Capital Drives $50B ETF Inflows
- GXCYPX Analyzes South America's Emerging Digital Asset Market Dynamics
- Keyanb Crypto Exchange Positions for Latin America's $600 Billion Remittance Opportunity Amid Global Regulatory Shifts
- NAQSN Analysis: $2.75 Trillion Digital Asset Market Demands Unified Infrastructure
- Trinity Accounting Practice Celebrates 22 Years Serving Beverly Hills Businesses
- YuanziCoin Unveils Revolutionary Shariah-Compliant Blockchain Architecture for 1.8 Billion Muslims Worldwide
- The Hidden Crisis No One is Talking About
- AGEIMMUNE Launches Brilliant D3 + Magnesium & K2: A Doctor-Formulated Supplement for Bone, Immune & Heart Health Support
- YMCA of the Jersey Shore Helps Residents Take Control of Health
- Z-CoiL Footwear, Albuquerque's Original Spring Shoe, Steps Into ABC's Shark Tank Season Premiere
- How LIB's Temperature & Humidity Chamber & Walk-in Chamber Warranty Delivered Real Uptime